Global Vasculitis Treatment Strategic Business Report 2022: 23 Players Featured Including AB Science, Astellas Pharma, AstraZeneca and Baxter International – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Vasculitis Treatment: Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.

The global market for Vasculitis Treatment estimated at US$418.3 Million in the year 2020, is projected to reach a revised size of US$567.3 Million by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027.

Biologics, one of the segments analyzed in the report, is projected to record a 5.3% CAGR and reach US$301.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Corticosteroids segment is readjusted to a revised 3.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $121.3 Million, While China is Forecast to Grow at 4% CAGR

The Vasculitis Treatment market in the U.S. is estimated at US$121.3 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$99.6 Million by the year 2027 trailing a CAGR of 4% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Immunosuppressants Segment to Record 3.9% CAGR

In the global Immunosuppressants segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$73.9 Million in the year 2020 will reach a projected size of US$97.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 23 Featured) –

• AB Science SA
• Ablynx NV
• Acorda Therapeutics, Inc.
• Antares Pharma, Inc.
• Astellas Pharma, Inc.
• AstraZeneca PLC
• Baxter International, Inc.
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Can-Fite BioPharma Ltd.
• Celgene Corporation
• Celltrion Healthcare Co., Ltd.
• Coherus BioSciences
• Daiichi Sankyo Co., Ltd.
• Eisai Co., Ltd.
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Gilead Sciences, Inc.
• GlaxoSmithKline PLC
• Hospira, Inc.
• Idera Pharmaceuticals, Inc.
• Immunomedics, Inc.
• Incyte Corporation
• Lexicon Pharmaceuticals, Inc.
• MedImmune LLC
• Merck & Co., Inc.
• Morphotek, Inc.
• Novartis AG
• Novo Nordisk A/S
• Regeneron Pharmaceuticals, Inc.
• Sandoz International GmbH
• Sanofi SA
• Takeda Pharmaceutical Co., Ltd.
• UCB SA
• Vertex Pharmaceuticals Inc.

What’s New for 2022?

• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies – Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Vasculitis Treatment – Global Key Competitors Percentage Market Share in 2022 (E)
• Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/toe7jq

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900